Virtual Medicinal Product (VMP)
-
Buprenorphine 2mg sublingual tablets sugar free
Name Details
Current Name
Buprenorphine 2mg sublingual tablets sugar free
|
Start Date
10-05-2004
|
End Date
|
Previous Name
Buprenorphine 2mg sublingual tablets
|
Start Date
21-10-2002
|
End Date
09-05-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 3 (CD No Register)
- Route
- Sublingual
- Form
- Sublingual tablet
- Ontology Form/Route
- tabletsublingual.oromucosal
- Free From
-
Sugar-free
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N07BC01
BNF |
Current BNF
04100300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04100300
|
Start Date
05-04-2011
|
End Date
03-04-2022
|
Previous BNF
04100000
|
Start Date
23-02-2005
|
End Date
04-04-2011
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42009111000001108 |
03-07-2023 |
|
322496005 |
21-10-2002 |
02-07-2023 |
VMP Ingredients
Name
Buprenorphine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Buprenorphine
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
Parent Products
-
VTM
Buprenorphine
-
VMP
(Current) Buprenorphine 2mg sublingual tablets...
Virtual Medicinal Product Pack (VMPP) Information